Most Recent
An Australian maker of neoprene handbags sold at high-end retailers has appealed its loss in a copyright dispute over alleged knockoffs, contesting a judge's finding that its trendy tote is not a work of artistic craftsmanship.
A judge has blasted AMP for dragging a fight over documents to court this close to Christmas, after software company DST Bluedoor revealed it is seeking $35.5 million in loss and damages against the financial services firm for allegedly inducing 11 employees to jump ship after licensing its online advisor platform.
The Australian maker of a trendy neoprene handbag sold at high-end retailers has lost a copyright lawsuit over alleged knockoffs, with a judge finding the tote was at most an "evolution in styling" and not a work of artistic craftsmanship with copyright protection.
The maker of pain killer Maxigesic is taking its long-running battle with Nuromol manufacturer Reckitt Benckiser to an appeals court after a recent ruling that its advertising misled consumers by claiming Maxigesic provided better, faster and more effective pain relief than paracetamol or ibuprofen.
AFT Pharmaceuticals has suffered another blow over its Maxigesic advertisements, with a judge finding the marketing material misled consumers by claiming to provide better, faster and more effective pain relief than paracetamol or ibuprofen.
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.
AFT Pharmaceuticals is seeking to reopen a lawsuit against Reckitt Benckiser over ads for its painkiller Maxigesic after judgment was delivered in the matter, claiming the judge's declarations contained an error, an argument slammed by Reckitt as "extraordinary".
A software company is suing a subsidiary of AMP for breach of contract after the financial services firm allegedly induced 11 employees to jump ship after licensing its online advisor platform.
AFT Pharmaceuticals has lost its challenge to a ruling that ads claiming its painkiller Maxigesic is more effective than Nuremol were misleading and deceptive, with the Full Federal Court saying the primary judge did not err in finding the ads lacked an adequate scientific basis.
International hip-hop superstar Jay-Z has sued an Australian children's book manufacturer for "flagrant, glaring and contumelious" intellectual property infringement with its 'AB to Jay-Z' baby books.